Eye's hidden lymphatic system may lead to new blindness treatments
This digest was compiled by AI from multiple sources — links to the originals are below.
Researchers from the University of British Columbia and the University of Toronto have discovered a previously unknown lymphatic drainage pathway in the back of the eye, challenging a century-old belief that the area lacks such a system. The finding could reshape treatment for glaucoma, age-related macular degeneration, and other blinding diseases. The team used advanced imaging on mice to trace fluid flow from the eye to nearby lymph nodes in real time.
The Discovery
For over a century, scientists believed the eye lacked a lymphatic system, which is present in most other organs to regulate fluid, remove waste, and support immune function. Researchers Nirupa Gupta and Yeni Yücel first challenged this idea in 2009 by identifying a lymphatic drainage pathway in the front of the eye, called the uveolymphatic pathway. The new study extends this finding to the back of the eye, where many blinding diseases originate. 'The retina is responsible for vision, and it is where many of the most serious blinding diseases arise,' Yücel said.
Experimental Methods
The team used a combination of MRI, near-infrared fluorescence, and microscopic analysis on mice. They injected fluorescent tracer molecules into the thin space at the back of the eye and tracked their movement in real time. This allowed them to identify small lymphatic vessels in the choroid, a layer beneath the retina. Fluid drained from the back of the eye into surrounding orbital tissues and reached nearby lymph nodes within minutes, connecting the eye to the broader lymphatic system.
Implications for Treatment
The discovery suggests an active clearance pathway in the back of the eye that may play a key role in removing fluid, proteins, and inflammatory substances that accumulate in disease. Researchers believe this could lead to improved drug delivery to the back of the eye, new therapies that enhance fluid drainage, and a better understanding of how pressure, inflammation, and fluid dynamics contribute to vision loss. However, further studies are needed to confirm the pathway's function in humans.
What's Next
The research team plans to investigate how the lymphatic pathway functions in human eyes and whether it can be targeted with therapeutic agents. It remains unclear how quickly such treatments could reach clinical trials or whether the pathway behaves identically in diseased eyes.
1 source
Eye's hidden lymphatic system may lead to new blindness treatments
